A German multicenter, randomized, controlled, open-label study of the Cypher sirolimus-eluting stent in the treatment of diabetic patients with de novo native coronary artery lesions.
Latest Information Update: 25 May 2012
At a glance
- Drugs Sirolimus (Primary)
- Indications Angina pectoris; Coronary artery disease; Coronary artery restenosis; Myocardial ischaemia
- Focus Therapeutic Use
- Acronyms SCORPIUS
- Sponsors Cordis Corporation
- 02 Dec 2009 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 31 Jul 2007 New trial record.